(VIANEWS) – Agree Realty Corporation (ADC), Eli Lilly and Company (LLY), The Pennant Group (PNTG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Agree Realty Corporation (ADC)
20.4% sales growth and 3.74% return on equity
Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of June 30, 2020, the Company owned and operated a portfolio of 936 properties, located in 46 states and containing approximately 18.4 million square feet of gross leasable area. The common stock of Agree Realty Corporation is listed on the New York Stock Exchange under the symbol "ADC".
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.79.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 37.39. Meaning, the purchaser of the share is investing $37.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.74%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 4.4% and a negative 6.5%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 27, 2023, the estimated forward annual dividend rate is 2.92 and the estimated forward annual dividend yield is 4.28%.
Yearly Top and Bottom Value
Agree Realty Corporation’s stock is valued at $66.92 at 11:22 EST, way below its 52-week high of $80.44 and higher than its 52-week low of $63.34.
2. Eli Lilly and Company (LLY)
15.4% sales growth and 54.79% return on equity
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.3.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 71.7. Meaning, the purchaser of the share is investing $71.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.79%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Eli Lilly and Company’s EBITDA is 212.65.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.9%, now sitting on 27.69B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 13, 2023, the estimated forward annual dividend rate is 4.52 and the estimated forward annual dividend yield is 0.99%.
Sales Growth
Eli Lilly and Company’s sales growth is 16.9% for the present quarter and 15.4% for the next.
3. The Pennant Group (PNTG)
12.1% sales growth and 6.54% return on equity
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Earnings Per Share
As for profitability, The Pennant Group has a trailing twelve months EPS of $0.25.
PE Ratio
The Pennant Group has a trailing twelve months price to earnings ratio of 44.96. Meaning, the purchaser of the share is investing $44.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.54%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11%, now sitting on 485.8M for the twelve trailing months.
4. ITT Corporation (ITT)
8.1% sales growth and 18.01% return on equity
ITT Inc. manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates through three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components; and sealing technologies primarily for the transportation industry, including passenger cars, light- and heavy-duty commercial and military vehicles, buses, and rail. The Industrial Process segment designs and manufactures industrial pumps, valves, and plant optimization systems; and centrifugal process pumps, twin screw, axials, and positive displacement pumps, and water systems, as well as aftermarket solutions, such as repairs and upgrades services. It serves various customers in industries, such as chemical, oil and gas, mining, and other industrial process markets. The Connect & Control Technologies segment designs and manufactures a range of engineered connectors and specialized control components for critical applications supporting various markets, including aerospace and defense, industrial, transportation, medical, and oil and gas. The connector product portfolio includes electrical connectors, such as circular, rectangular, radio frequency, fiber optic, D-sub miniature, micro-miniature, and cable assemblies; and control products consist of fuel and water pumps, valves, electro-mechanical rotary and linear actuators, and pressure, temperature, limit, and flow switches for various aircraft systems. ITT Inc. was founded in 1920 and is headquartered in White Plains, New York.
Earnings Per Share
As for profitability, ITT Corporation has a trailing twelve months EPS of $4.72.
PE Ratio
ITT Corporation has a trailing twelve months price to earnings ratio of 20.96. Meaning, the purchaser of the share is investing $20.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.01%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 3.06B for the twelve trailing months.
5. International General Insurance Holdings Ltd. (IGIC)
8% sales growth and 23.67% return on equity
International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance segments. It offers a portfolio of specialty lines insurance products and services for energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine liability, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.
Earnings Per Share
As for profitability, International General Insurance Holdings Ltd. has a trailing twelve months EPS of $1.99.
PE Ratio
International General Insurance Holdings Ltd. has a trailing twelve months price to earnings ratio of 4.43. Meaning, the purchaser of the share is investing $4.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.67%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31.4%, now sitting on 453.12M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 3.3% and a negative 14.3%, respectively.
Volume
Today’s last reported volume for International General Insurance Holdings Ltd. is 26065 which is 46.18% below its average volume of 48436.
Sales Growth
International General Insurance Holdings Ltd.’s sales growth is 7% for the present quarter and 8% for the next.
6. Owens (OI)
6.2% sales growth and 47.84% return on equity
O-I Glass, Inc., through its subsidiaries, engages in the manufacture and sale of glass containers to food and beverage manufacturers primarily in the Americas, Europe, and internationally. The company produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. It is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. In addition, the company offers glass containers in a range of sizes, shapes, and colors. It sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. The company was founded in 1903 and is headquartered in Perrysburg, Ohio.
Earnings Per Share
As for profitability, Owens has a trailing twelve months EPS of $4.36.
PE Ratio
Owens has a trailing twelve months price to earnings ratio of 5.28. Meaning, the purchaser of the share is investing $5.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.84%.
Volume
Today’s last reported volume for Owens is 160611 which is 81.85% below its average volume of 885140.
